Jim Simons
IMNM icon

Jim Simons’s Immunome IMNM Stock Holding History

Jim Simons’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32M Buy
251,102
+182,200
+264% +$3.9M 0.01% 1427
2026
Q1 		$1.51M Buy
+68,902
New +$1.53M ﹤0.01% 2043
2025
Q4 		– Sell
-202,300
Closed -$2.37M – 3479
2025
Q3 		$2.37M Buy
202,300
+102,928
+104% +$1.02M ﹤0.01% 1959
2025
Q2 		$924K Sell
99,372
-16,628
-14% -$136K ﹤0.01% 2558
2025
Q1 		$781K Sell
116,000
-200,000
-63% -$1.92M ﹤0.01% 2550
2024
Q4 		$3.36M Buy
316,000
+304,700
+2,696% +$3.68M 0.01% 1702
2024
Q3 		$165K Sell
11,300
-82,000
-88% -$1.17M ﹤0.01% 3160
2024
Q2 		$1.13M Buy
93,300
+47,782
+105% +$747K ﹤0.01% 2256
2024
Q1 		$1.12M Sell
45,518
-75,982
-63% -$1.54M ﹤0.01% 2415
2023
Q4 		$1.3M Buy
121,500
+89,100
+275% +$741K ﹤0.01% 2228
2023
Q3 		$271K Sell
32,400
-12,100
-27% -$88.9K ﹤0.01% 2982
2023
Q2 		$352K Buy
44,500
+15,600
+54% +$85.3K ﹤0.01% 3059
2023
Q1 		$144K Buy
28,900
+7,800
+37% +$38.1K ﹤0.01% 3383
2022
Q4 		$47K Sell
21,100
-400
-2% -$1.61K ﹤0.01% 3808
2022
Q3 		$95K Hold
21,500
– – ﹤0.01% 3613
2022
Q2 		$69K Buy
21,500
+7,500
+54% +$27.3K ﹤0.01% 3936
2022
Q1 		$80K Buy
+14,000
New +$105K ﹤0.01% 3829
2021
Q3 		– Sell
-20,400
Closed -$353K – 3637
2021
Q2 		$353K Buy
+20,400
New +$451K ﹤0.01% 3089

Other funds holding IMNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jim Simons's IMNM Position: Q2 2026 in Review

Jim Simons increased its Immunome (IMNM) stake by 264% in Q2 2026, buying an estimated $3.9M and bringing the position to 251,102 shares worth $5.32M. The position accounts for 0.01% of the portfolio, ranked #1427.

Jim Simons first reported a position in IMNM in Q2 2021 and has held it in 18 quarters since. 125 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Jim Simons held 251,102 shares of Immunome worth $5.32M as of Q2 2026.
  • Jim Simons bought 182,200 Immunome shares in Q2 2026, an estimated $3.9M.
  • Immunome made up 0.01% of Jim Simons's portfolio in Q2 2026, its #1427 holding.
  • Jim Simons first reported a position in Immunome in Q2 2021 and has held it in 18 quarters since.
  • 125 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.